Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic
Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic
MVA-BN or Modified Vaccinia Ankara-On Thursday, the European Commission said around 100,000 mpox vaccine doses arrived in the Democratic Republic of Congo (DRC), making these the first delivery of the vaccine to the country.
周四，欧洲委员会表示，约有10万剂mpox疫苗运抵刚果民主共和国（DRC），成为该国首批疫苗输送。
A second delivery amounting to around 100,000 vaccines is expected to arrive in the coming days.
预计在未来几天内将有大约10万剂疫苗的第二批运抵。
These vaccines are part of the 215,000 MVA-BN vaccine doses that the European Commission's Health Emergency Preparedness and Response Authority procured and pledged to share with affected African countries as an immediate response to the mpox outbreak.
这些疫苗是欧洲委员会卫生紧急事务与反应局采购的21.5万剂MVA-BN疫苗之一，承诺与受影响的非洲国家共享，作为对mpox爆发的直接应对。
MVA-BN or Modified Vaccinia Ankara-Bavarian Nordic A/S (OTC:BVNRY) (OTC:BVNKF) is a non-replicating smallpox vaccine and the only mpox vaccine approved in the EU/EEA and the U.K. (marketed as Imvanex), the U.S. and Switzerland (marketed as Jynneos), and in Canada (marketed as Imvamune).
MVA-BN或Modified Vaccinia Ankara-Bavarian Nordic A/S（OTC: BVNRY）（OTC: BVNKF）是一种非复制性天花疫苗，也是唯一获得欧盟/欧洲经济区和英国批准的mpox疫苗（市场上称为Imvanex），以及美国和瑞士（市场上称为Jynneos）以及加拿大（市场上称为Imvamune）。
An additional 351,500 doses from France, Germany, Spain, Malta, Portugal, Luxembourg, Croatia, Austria, Poland, and potentially some other Member States will be donated to the Africa CDC to distribute to affected countries.
法国、德国、西班牙、马耳他、葡萄牙、卢森堡、克罗地亚、奥地利、波兰和可能其他一些成员国的额外35.15万剂疫苗将捐赠给非洲疾病控制与预防中心（Africa CDC），以分发给受影响的国家。
This brings the total vaccine doses donated from Team Europe to at least 566,500.
这将使Team Europe捐赠的疫苗总剂量至少达到56.65万剂。
Congo received the doses on Thursday, more than 18 months after the country declared the situation an epidemic.
刚果在宣布该国疫情为流行病后的18个多月后于周四收到了这些疫苗。
Assigning blame for the sluggish distribution of mpox vaccines in Congo proves challenging due to a multitude of factors, the NPR report notes.
《全国公共电台》的报道指出，由于多种因素，很难归咎于刚果mpox疫苗分发缓慢的问题。
As of June 27, Congo's regulatory body had not approved mpox vaccines for use. Subsequent donations from the U.S. have been stalled as the Congolese government finalizes pre-shipment requirements, such as proper vaccine storage and handling.
截至6月27日，刚果的监管机构尚未批准使用mpox疫苗。随后，美国的捐赠因刚果政府正在完成发运前的要求，比如正确的疫苗储存和处理，而被搁置。
Many low- and middle-income countries rely on the World Health Organization (WHO) to evaluate vaccine safety and efficacy. Yet, the WHO has not approved any mpox vaccines, still relatively new, despite their authorization by U.S. and European health authorities during the global mpox outbreak in 2022.
许多低收入和中等收入国家依赖世界卫生组织（WHO）评估疫苗的安全性和有效性。然而，尽管在2022年全球mpox爆发期间获得美国和欧洲卫生当局的授权，WHO仍未批准任何mpox疫苗，这些疫苗仍然相对较新。
There remain significant unknowns about the vaccines, especially regarding their effectiveness against the virus strain currently spreading in Congo, which has evolved into a new variant.
对于这些疫苗仍存在重要的未知因素，尤其是它们对目前在刚果传播的病毒株的有效性，该病毒株已经演变成一种新变种。
The African response to the mpox crisis mirrors past challenges faced during the COVID pandemic when vaccine access was severely limited for lower-income nations.
对于低收入国家来说，在mpox危机中的非洲应对措施与过去COVID大流行时期面临的挑战相似，即疫苗获取对这些国家严重受限。
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
免责声明：本内容部分使用人工智能工具生成，并经Benzinga编辑审核发布。
- What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday?
- 周五，与低价股和血癌公司Vor Biopharma有什么新发展？
Photo by NIAID via Flickr
图片由NIAID通过Flickr提供